Sofosbuvir and Ledipasvir
HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF DRUG RELEASE OF LEDIPASVIR AND SOFOSBUVIR IN LEDIPASVIR AND SOFOSBUVIR TABLETS
... of Ledipasvir and Sofosbuvir in Ledipasvir and Sofosbuvir tablets used for the treatment of chronic hepatitis C virus (HCV) ...of Sofosbuvir and Ledipasvir ...of ...
8
Response of HCV Yemeni Patients to Sofosbuvir/Ledipasvir in Combination with Ribavirin
... of Sofosbuvir, as NS5B polymerase inhibitor with potent activity against all 6 HCV genotypes (pangenotypic activity) ...of Sofosbuvir and ledipasvir with or without Ribavirin for 12 weeks [22] ...of ...
9
Development and Validation of Stability indicating RP- HPLC method for Simultaneous Estimation of Sofosbuvir and Ledipasvir in Bulk Tablet Dosage Form
... A simple, fast, accurate and precise stability- indicating HPLC analytical method has been developed and validated for the Quantitative analysis of Sofosbuvir and Ledipasvir in combined tablet dosage forms. ...
10
Development and Validation of a Stability-indicating Method for the Simultaneous Estimation of Sofosbuvir and Ledipasvir by RP-HPLC
... µg/ml sofosbuvir and 90 µg/ml ledipasvir) prepared by accurately weighed amount of sofosbuvir (40 mg) and ledipasvir (9 mg) standard drugs were dissolved in 10 ml of ...of sofosbuvir ...
7
DEVELOPMENT AND VALIDATION OF STABILITY INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF SOFOSBUVIR AND LEDIPASVIR IN TABLET DOSAGE FORMM.Prasanthi Evangelin*, S.Manohar Babu, Konda Ravi KumarDOWNLOAD/VIEW
... bonded[4,5]. Sofosbuvir is a prodrug nucleotide analog used as part of combination therapy to treat hepatitis C virus (HCV) infection or to treat co-infection of HIV and ...HCV. Sofosbuvir and other ...
7
VALIDATED CAPILLARY ZONE ELECTROPHORESIS APPROACH FOR SIMULTANEOUS SEPARATION AND DETERMINATION OF HEPATITIS C SOFOSBUVIR AND LEDIPASVIR IN TABLET DOSAGE FORM
... Materials and reagents: To detect the selected hepatitis C drugs SOF and LDV, all chemicals are pure analytical grade and the spectroscopic HPLC solvents were used. 0.1mol L -1 of glacial acetic acid as well as sodium ...
19
“Development of validated specific stability-indicating HPTLC method for the simultaneous determination of Ledipasvir and Sofosbuvir in fixed dose tablet formulation”
... of ledipasvir and sofosbuvir in combined dosage ...of sofosbuvir and ledipasvir were observed to be ...for ledipasvir and sofosbuvir, ...indicated ledipasvir to be ...
16
DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF LEDIPASVIR AND SOFOSBUVIR IN BULK AND PHARMACEUTICAL DOSAGE FORM
... mm × 4.6 mm, 5μm), using the mobile phase (Methanol: Water 83:17 v/v) pH 3.0 with 0.05% acidic acid at a flow rate of 1.0 ml/min, injection volume 20μl and UV detection at 245 nm. This method is validated according to ...
8
A NEW VALIDATED STABILITY INDICATING RP HPLC METHOD FOR SIMUTANEOUS ESTIMATION OF SOFOSBUVIR AND LEDIPASVIR IN TABLET DOSAGE FORMS
... Forced degradation is a degradation of new drug substances and drug products at conditions more than accelerated conditions. This studies show the chemical behavior of the molecules which in turn helps the development of ...
16
IMPLEMENTATION OF QUALITY BY DESIGN APPROACH TO DEVELOP AND VALIDATE STABILITY INDICATING ASSAY METHOD FOR SIMULTANEOUS ESTIMATION OF SOFOSBUVIR AND LEDIPASVIR IN BULK DRUGS AND TABLET FORMULATION
... QbD.‟ Sofosbuvir is more polar than ledipasvir. Ledipasvir has more pKa value than sofosbuvir hence ledipasvir is insoluble in water, and it gets precipitate in ...for sofosbuvir ...
9
The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon based treatment with first generation protease inhibitors a multicenter cohort study
... with ledipasvir/sofos- buvir ±RBV (LSR) and sofosbuvir + daclatasvir (SOF + DCV), to be used in patients with a history of prior BOC + PegIFN+RBV or TVR + PegIFN+RBV ...
9
Early sofosbuvir ledipasvir treatment for acute HCV infection induced severe immune thrombocytopenia – a case report
... therefore a 12 weeks course of sofosbuvir-ledipasvir was indicated. At initiation of the treatment, the platelet count was 43 G/L and HCV viral load was 6.3 log IU/mL. At day 15 of antiviral treatment, HCV ...
5
Simultaneous chromatographic analysis of Sofosbuvir/Ledipasvir in their combined dosage form: an application to green analytical chemistry
... Sofosbuvir (SBR) is a new drug used for treating hepatitis C viral infection. Hepatitis C virus (HCV) infects the liver and has many complications which might need liver transplant- ation (Jacobson et al. 2010; ...
12
Post Hepatitis C Cirrhosis in Sub Sahara Kidney Transplant, Treated with Sofosbuvir/Ledipasvir: Report of Case and Review of Literature
... DOI: 10.4236/ojneph.2017.74011 97 Open Journal of Nephrology was at 5,242,045 UI/ml (6.72 log). The patient had a genotype HCV 2a/2c. Alpha fetoprotein was normal (6.39 ng/ml). Retroviral Human Immunodeficiency Vi- rus ...
6
Reactivation of occult HBV infection in an HIV/HCV Co infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature
... Background: Reactivation of occult or inactive Hepatitis B virus (HBV) infection during immunosuppressant treatments is well known and widely described in literature. The same observation has been made in Hepatitis C ...
5
Combination ledipasvir-sofosbuvir for the treatment of chronic hepatitis C virus infection: a review and clinical perspective
... agents, ledipasvir 90 mg (anti-NS5A) and sofosbuvir 400 mg (anti-NS5B), has been approved in the US and the Euro- pean Union for the treatment of chronic hepatitis C viral ...the ...
12
Development of Validated UV Spectroscopic, HPTLC and RP-HPLC Methods for the Simultaneous Estimation of Ledipasvir and Sofosbuvir in Pure and Fixed Dose Combination
... Ideal solvent is the one which completely solublize the drug and should maintain good stability of the drug in solution. Initially solvents like acetone and methanol were tried, among these spectrum of ledipasvir ...
162
Glomerular filtration rate change during chronic hepatitis C treatment with Sofosbuvir/Ledipasvir in HCV/HIV Coinfected patients treated with Tenofovir and a boosted protease inhibitor: an observational prospective study
... of sofosbuvir (SOF), a nucleotide NS5B polymerase inhibitor, and ledipasvir (LDV), an inhibitor of nonstructural protein 5A (NS5A), is one of the possible treatment options for HCV geno- types 1 and 4, and ...
6
Clinical utility of ledipasvir/sofosbuvir in the treatment of adolescents and children with hepatitis C
... Abstract: Chronic infection with hepatitis C virus (HCV) affects an estimated 0.1%–2% of the pediatric population in the United States. While the clinical course in young children is indolent, adolescents who contract ...
8
Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
... of ledipasvir/sofosbuvir provides several advantages compared to other regimens, including use of a single-pill regimen, possibility to shorten the duration of treatment to 8 weeks, efficacy in patients ...
6